
TLE3 Protein, Human, Recombinant (aa 484-772, GST) NEW
Price | $700 |
Package | 100μg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-07-18 |
Product Details
Product Name: TLE3 Protein, Human, Recombinant (aa 484-772, GST) | Supply Ability: 10g |
Release date: 2025/07/18 |
Product Introduction
Bioactivity
Name | TLE3 Protein, Human, Recombinant (aa 484-772, GST) |
Description | The association between high TLE3 expression and a favorable response to taxane-containing chemotherapy regimens was validated in patients with non-serous ovarian cancer. That TLE3 expression may serve as a marker of chemosensitivity in taxane-treated patients with non-serous histologies. Transducin-like enhancer of Split3 (TLE3) serves as a transcriptional corepressor during cell differentiation and shows multiple roles in different kinds of cancers. TLE3 repressed CRC proliferation partly through inhibition of MAPK and AKT signaling pathways, suggesting the possibility of TLE3 as a biomarker for CRC prognosis. |
Storage | Shipping with blue ice/Shipping at ambient temperature. |
Keywords | HsT-18976 | HsT 18976 | GRG-3 | GRG 3 | ESG-3 | ESG 3 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$1830.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-06-24 | |
$1680.00/1mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$0.00/1G |
VIP1Y
|
Shenzhen Nexcon Pharmatechs Ltd.
|
2025-06-03 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY